| Title |
Fingerprint changes among cancer patients treated with paclitaxel
|
|---|---|
| Published in |
Journal of Cancer Research and Clinical Oncology, December 2016
|
| DOI | 10.1007/s00432-016-2314-1 |
| Pubmed ID | |
| Authors |
Payam Azadeh, Simin Dashti-Khavidaki, Ali Yaghobi Joybari, Samaneh Sarbaz, Atefeh Jafari, Mehdi Yaseri, Afshin Amini, Maryam Farasatinasab |
| Abstract |
Fingerprints have long been used for personal identification; however, some case reports suggested that some chemotherapy agents such as paclitaxel lead to fingerprints loss due to hand-and-foot syndrome (HFS). This case-control study was performed on 65 patients who received chemotherapy regimens with/without paclitaxel. Patients with the history of receiving any drugs with significant HFS adverse effect or patients with any conditions that affect fingerprints were excluded. Baseline and post-chemotherapy images of fingerprint examples were referred to the Iranian Society of Legal Medicine to compare changes in the fingerprints. Thirty-one patients entered in the paclitaxel and 34 subjects in the control groups. Seventeen patients (54.8%) in the paclitaxel group experienced fingerprint changes, whereas no patient had fingerprint changes in the control group. By physical examination, no patients in the two groups experienced HFS. After adjusting for age, sex, occupation, and cancer type, there was a significant difference between the two groups regarding fingerprint changes (P = 0.002, OR 13.69, 95% CI 2.05 to infinite). Considering that fingerprint recognition has been utilized in both government and civilian investigation, patients taking paclitaxel and centers necessitating fingerprint identification should be informed about possible fingerprint changes by paclitaxel. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 33% |
| Curaçao | 1 | 17% |
| Australia | 1 | 17% |
| Unknown | 2 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 3 | 50% |
| Members of the public | 3 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 33 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 4 | 12% |
| Student > Bachelor | 3 | 9% |
| Professor | 2 | 6% |
| Student > Doctoral Student | 1 | 3% |
| Lecturer > Senior Lecturer | 1 | 3% |
| Other | 5 | 15% |
| Unknown | 17 | 52% |
| Readers by discipline | Count | As % |
|---|---|---|
| Nursing and Health Professions | 2 | 6% |
| Medicine and Dentistry | 2 | 6% |
| Psychology | 2 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
| Computer Science | 1 | 3% |
| Other | 6 | 18% |
| Unknown | 19 | 58% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2022.
All research outputs
#7,493,843
of 24,892,887 outputs
Outputs from Journal of Cancer Research and Clinical Oncology
#560
of 2,791 outputs
Outputs of similar age
#120,163
of 406,133 outputs
Outputs of similar age from Journal of Cancer Research and Clinical Oncology
#2
of 13 outputs
Altmetric has tracked 24,892,887 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 2,791 research outputs from this source. They receive a mean Attention Score of 3.7. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 406,133 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.